Kaplan S - Search Results

1

Pregnancy and Infant Outcomes in Women with Multiple Sclerosis Exposed to Glatiramer Acetate Therapy: An Extended 4-Year Safety Update.

Kaplan S, Ghimpeteanu A, Dragut CF. Kaplan S, et al. Drug Saf. 2025 Jun;48(6):697-713. doi: 10.1007/s40264-025-01523-y. Epub 2025 Mar 19. Drug Saf. 2025. PMID: 40106171

2

Challenges of post-authorization safety studies: Lessons learned and results of a French study of fentanyl buccal tablet.

Gavrielov-Yusim N, Bidollari I, Kaplan S, Bartov N. Gavrielov-Yusim N, et al. Among authors: kaplan s. Pharmacoepidemiol Drug Saf. 2018 May;27(5):457-463. doi: 10.1002/pds.4331. Epub 2017 Oct 13. Pharmacoepidemiol Drug Saf. 2018. PMID: 29027301 Review.

3

Effectiveness of Risk Minimization Measures for Fentanyl Buccal Tablet (FENTORA) in Canada: A Mixed-Methods Evaluation Using Surveys, Medical Chart Records and Web Surveillance.

Kaplan S, Bergamasco A, Sergerie M, Castilloux AM, Moride Y. Kaplan S, et al. Drug Saf. 2020 Feb;43(2):163-177. doi: 10.1007/s40264-019-00882-7. Drug Saf. 2020. PMID: 31691255

4

The risk of melanoma with rasagiline compared with other antiparkinsonian medications: A retrospective cohort study in the United States medicare database.

Johannes CB, Saltus CW, Kaye JA, Calingaert B, Kaplan S, Gordon MF, Andrews EB. Johannes CB, et al. Among authors: kaplan s. Pharmacoepidemiol Drug Saf. 2022 Jun;31(6):643-651. doi: 10.1002/pds.5422. Epub 2022 Apr 6. Pharmacoepidemiol Drug Saf. 2022. PMID: 35224798 Free PMC article.

5

Pregnancy, Fetal, and Infant Outcomes Following Maternal Exposure to Glatiramer Acetate During Pregnancy and Breastfeeding.

Kaplan S, Zeygarnik M, Stern T. Kaplan S, et al. Drug Saf. 2022 Apr;45(4):345-357. doi: 10.1007/s40264-022-01168-1. Epub 2022 Mar 16. Drug Saf. 2022. PMID: 35297004

6

Delayed pregnancy detection and return to fertility with extended levonorgestrel-containing oral contraceptives: A real world setting cohort study.

Kaplan S, Bertoia ML, Lass A, Wang FT, Evans A, Dhanda S, Roy D, Seeger JD. Kaplan S, et al. Pharmacoepidemiol Drug Saf. 2023 Jan;32(1):78-83. doi: 10.1002/pds.5497. Epub 2022 Jun 30. Pharmacoepidemiol Drug Saf. 2023. PMID: 35713281

7

Pregnancy and fetal outcomes following maternal exposure to glatiramer acetate in all three trimesters of pregnancy.

Kaplan S, Zeygarnik M, Stern T, Hellwig K. Kaplan S, et al. Eur J Neurol. 2023 Dec;30(12):3890-3895. doi: 10.1111/ene.16036. Epub 2023 Aug 24. Eur J Neurol. 2023. PMID: 37565380

8

Pregnancy and fetal outcomes following paternal exposure to glatiramer acetate.

Kaplan S, Dragut CF, Ghimpeteanu A. Kaplan S, et al. Curr Med Res Opin. 2024 May;40(5):821-825. doi: 10.1080/03007995.2024.2337669. Epub 2024 Apr 13. Curr Med Res Opin. 2024. PMID: 38577712

9

Modafinil and the risk of cardiovascular events: Findings from three US claims databases.

Kaplan S, Goehring EL Jr, Melamed-Gal S, Nguyen-Khoa BA, Knebel H, Jones JK. Kaplan S, et al. Pharmacoepidemiol Drug Saf. 2018 Nov;27(11):1182-1190. doi: 10.1002/pds.4642. Epub 2018 Aug 14. Pharmacoepidemiol Drug Saf. 2018. PMID: 30106194

10

Assessment of colistimethate sodium (COLOBREATHE) risk minimization measures implemented in the European Union: A cross-sectional study.

Kaplan S, Patino O, Rainville C, Madison T. Kaplan S, et al. Pharmacoepidemiol Drug Saf. 2020 Feb;29(2):219-223. doi: 10.1002/pds.4940. Epub 2019 Dec 9. Pharmacoepidemiol Drug Saf. 2020. PMID: 32914920

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,233 results

Search Page

Filters